Multiple system atrophy (MSA)
Would you like to receive a message when there is new research about Multiple System Atrophy (MSA)? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, above every publication you'll see one sentence explaining what was studied — and you'll receive a message as soon as there is new research about Multiple System Atrophy (MSA). View what Premium costs.
Publications and studies (1558)
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Dual Sympathetic Blocks for Patients Experiencing Sympathetically-Mediated Symptoms From Long COVID (2025-03-13) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Effects of a Multi-intervention Programme for the Elderly (2025-03-12) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Multi-Center Study Protocol: Impact of Sarcopenia in Early-Onset Colorectal Cancer. (2025-03-12) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Parkinson Atypical Rating of Oculometric Patterns Evaluated Routinely (2025-03-11) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Two-Part Study for Dose Determination of Vesleteplirsen (SRP-5051) (Part A), Then Dose Expansion (Part B) in Participants With Duchenne Muscular Dystrophy Amenable to Exon 51-Skipping Treatment (2025-03-10) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. NYSCF Scientific Discovery Biobank (2025-03-03) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Proof of Mechanism Study to Evaluate Binding of Alfa-synuclein (2025-02-20) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Transcutaneous Spinal Cord Stimulation Home Study (2025-02-20) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Study to Evaluate a Potential PET Radioligand for Imaging Alpha-synuclein Deposits in the Brain (2025-02-19) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. [18F]-MFBG Versus [123I]-MIBG and [18F]-PE2I in PD vs. MSA and DLB vs. AD (2025-02-06) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Medical Decision Making in Multiple System Atrophy (2025-02-05) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Study to Evaluate Investigational Allogeneic Cell Therapy Product hOMSC300 for Treatment of Early to Moderate Stage Multiple System Atrophy (MSA) (2025-01-29) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. The NADAPT Study: a Randomized Double-blind Trial of NAD Replenishment Therapy for Atypical Parkinsonism (2025-01-10) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. HOPE-Duchenne (Halt cardiomyOPathy progrEssion in Duchenne) (2025-01-09) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Prodromal Model of Parkinson's Disease Confined to The Peripheral Nervous System (2025-01-08) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Long-term Follow-up of Phase 1 Clinical Trial of CS10BR05(CS10BR05-MSA101) (2025-01-07) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Myelopathy as the first manifestation of AIDS. (2024/12/31) ♡
- N-terminus α-synuclein detection reveals new and more diverse aggregate morphologies in multiple system atrophy and Parkinson's disease. (2024/12/27) ♡
- Clinical utility of synuclein skin biopsy in the diagnosis and evaluation of synucleinopathies. (2024/12/18) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Exploring the Role of Axons in ALS from Multiple Perspectives. (2024/12/17) ♡
- Serum neurofilament light chain as a diagnostic and prognostic biomarker in multiple system atrophy: a prospective cohort study. (2024/12/16) ♡
- Differentiating atypical parkinsonian syndromes with hyperbolic few-shot contrastive learning. (2024/12/15) ♡
- How to distinguish spinocerebellar ataxia 27B from late onset cerebellar ataxia: insights from a case-control study. (2024/12/12) ♡
- Myelin basic protein and TREM2 quantification in the CSF of patients with Multiple System Atrophy and other Parkinsonian conditions. (2024/12/12) ♡
- Current Landscape of Clinical Diagnosis in Multiple System Atrophy: A 15-Year Analysis From 2008 to 2022. (2024/12/10) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The Role of Hypothalamic Microglia in the Onset of Insulin Resistance and Type 2 Diabetes: A Neuro-Immune Perspective. (2024/12/07) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. A-synuclein prion strains differentially adapt after passage in mice. (2024/12/06) ♡
- Neurodegeneration in the cortical sulcus is a feature of chronic traumatic encephalopathy and associated with repetitive head impacts. (2024/12/06) ♡
- Clinical and Laboratory Features Predict Phenoconversion from Sporadic Adult-onset Ataxia to Multiple System Atrophy. (2024/12/05) ♡
- Correction: Bright middle cerebellar peduncle sign in multiple system atrophy with predominant cerebellar ataxia is more apparent in double-inversion recovery imaging than in conventional imaging. (2024/12/02) ♡
- Spatial discrimination in patients with MSA, PSP, DIP, and VP with pain. (2024/12/02) ♡
- Probing the diagnostic values of plasma cf-nDNA and cf-mtDNA for Parkinson's disease and multiple system atrophy. (2024/12/02) ♡
- Monocyte to high-density lipoprotein cholesterol ratio reflects the peripheral inflammatory state in parkinsonian disorders. (2024/12/01) ♡
- Additive effects of cerebrovascular disease functional connectome phenotype and plasma p-tau181 on longitudinal neurodegeneration and cognitive outcomes. (2024/12/01) ♡
- A new seed amplification assay to diagnose multiple system atrophy. (2024/12/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Sensitivity and specificity of a seed amplification assay for diagnosis of multiple system atrophy: a multicentre cohort study. (2024/12/01) ♡
- Post-mortem neuropathology of idiopathic rapid eye movement sleep behaviour disorder: a case series. (2024/12/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Multiple system atrophy: advances in pathophysiology, diagnosis, and treatment. (2024/12/01) ♡
- Lewy-MSA hybrid fold drives distinct neuronal α-synuclein pathology. (2024/11/28) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Cold stress, heart failure, and esophageal occlusion cause the death of a West Indian manatee Trichechus manatus in Alabama, USA. (2024/11/28) ♡
- RNA G-quadruplexes form scaffolds that promote neuropathological α-synuclein aggregation. (2024/11/27) ♡
- Sexually dimorphic differences in angiogenesis markers are associated with brain aging trajectories in humans. (2024/11/27) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Brain-derived and in vitro-seeded alpha-synuclein fibrils exhibit distinct biophysical profiles. (2024/11/25) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Treatment advances of sepsis-induced myopathy (Review). (2024/11/25) ♡
- Neuroprotective effect of L-DOPA-induced interleukin-13 on striatonigral degeneration in cerebral ischemia. (2024/11/22) ♡
- Relation of CMV and brain atrophy to trajectories of immunosenescence in diverse populations. (2024/11/21) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. α-Synuclein seeding amplification assays for diagnosing synucleinopathies: an innovative tool in clinical implementation. (2024/11/21) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Targeting Protein Misfolding and Aggregation as a Therapeutic Perspective in Neurodegenerative Disorders. (2024/11/20) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. In Vitro Cell Model Investigation of Alpha-Synuclein Aggregate Morphology Using Spectroscopic Imaging. (2024/11/20) ♡
- Bright middle cerebellar peduncle sign in multiple system atrophy with predominant cerebellar ataxia is more apparent in double-inversion recovery imaging than in conventional imaging. (2024/11/13) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.